Mereo BioPharma Group Stock (NASDAQ: MREO)

Mereo BioPharma Group

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

ServiceNow

News

Initiation

Markets

Analyst Ratings

Trading Ideas

MREO

RCEL

This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

Energy stocks

Earnings

Eurozone

Commodities

AKTS

LAES

Larimar Therapeutics, Inc. - Common Stock

LRMR

WBUY

Crude Oil Down 1%; Webuy Global Shares Spike Higher

Constellation Brands

Price Target

Pre-Market Outlook

GKOS

This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group PLC

Press Releases

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

Financing

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

RARE

Absci

Akebia Therapeutics

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Altimmune

Arcturus Therapeutics Holdings Inc. - Common Stock

Arcturus Therapeutics

Astria Therapeutics

Aura Biosciences

Candel Therapeutics

Celcuity

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Erasca

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Heron Therapeutics

Humacyte

Oruka Therapeutics

PureTech Health plc - American Depositary Shares

PureTech Health

Rigel Pharmaceuticals, Inc. - Common Stock

Rigel Pharmaceuticals

Solid Biosciences

Stoke Therapeutics

Savara

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Entrada Therapeutics, Inc. - Common Stock

Entrada Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Needham

LifeSci Capital

Jefferies

Cantor Fitzgerald

Leerink Partners

Comments

Mereo BioPharma Group

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga